Basal cell carcinoma: the most common skin cancer

Written in association with: Dr Raj Mallipeddi
Published:
Edited by: Emma McLeod

Basal cell carcinoma (BCC) is the most common type of skin cancer and can make itself known in several ways. Fortunately, treatment is available. By reading this article by Dr Raj Mallipedi, a leading London dermatologist and specialist in skin cancer, you’ll understand how basal cell carcinoma manifests, what causes it and how it’s treated.

The left side of a woman's face with the focus on the cheek and the side of the nose, two areas that frequently receive sun exposure.

What is basal cell carcinoma?

Basal cell carcinoma (BCC) is the most common form of skin cancer. Fortunately, it’s usually only locally invasive – meaning it does not spread beyond the skin where it first appears. Such tumours show symptoms in a variety of ways depending on the subtype and may manifest as a pearly pink/red nodulea red scaly patchan ulcer or it could even have a scar-like appearance.

 

What causes basal cell carcinoma?

Basal cell carcinoma is most commonly a result of chronic sun exposure or repeated sunburn in fairer skinned individuals. However, some cases arise from inherited genetic conditions such as Gorlin's syndrome. Other risk factors include exposure to ionising radiation and immune suppression, either from disease or medication.

 

How is basal cell carcinoma treated?

There are many different forms of treatment. These depend on various factors:

  • The site of the basal cell carcinoma
  • Its size
  • Histological features (the cell behaviour on a microscopic level)
  • Individual patient variables

 

Surgical excision is the most common treatment option but radiotherapy is employed where surgery is not appropriate. In higher-risk tumours where the margins (edges) of the tumours are difficult to define or where tumours recur following previous treatments, a specialised form of surgery known as Mohs micrographic surgery can be beneficial. (See Mr Mallipeddi’s articles on Mohs surgery - ‘ What you need to know about Mohs surgery and slow Mohs surgery ’ and ‘ How successful is Mohs surgery?’)

 

On the other end of the spectrum, even creams can be used for superficial lesions. Photodynamic therapy, which combines the use of cream and light, is another option for such low-risk tumours.

 

How dangerous is basal cell carcinoma?

Basal cell carcinomas tend to grow slowly but over time can ulcerate and bleed. Fortunately, they usually respond to treatment and are rarely life-threatening.

 

Can basal cell carcinoma go away on its own?

Basal cell carcinomas do not generally go away on their own. Sometimes, they may seem to be less prominent depending on the degree of skin inflammation around the tumour. However, it is important to note the tumour cells are often beneath the skin surface and not visible to the naked eye.

 

Dr Mallipeddi is trained and experienced in the latest treatments for skin cancer. Learn more about how he can help you – click here.

By Dr Raj Mallipeddi
Dermatology

Dr Raj Mallipeddi is an award-winning consultant dermatological surgeon based in London who specialises in skin cancer, cosmetic dermatology and surgical dermatology alongside Mohs surgery, laser surgery, and photodynamic surgery. He practices privately for HCA Sydney Street Outpatient Centre, Dermatological Surgery, Laser Unit at Guy's Hospital Cancer Centre, and Bupa Cromwell Hospital. He also works for the Guy's and St Thomas' NHS Foundation Trust.

Dr Mallipeddi is well respected in the dermatology and skin cancer field, working in lead roles at top centres in the capital. He is the lead clinician for dermatological surgery and the laser unit at St John's Institute of Dermatology at Guy's Hospital Cancer Centre and was the lead consultant for skin cancer for his NHS trust, seeing referrals from all over the UK. Dr Mallipeddi studied at Imperial College in London where he was awarded an MBBS in 1997. During this time, he also completed an intercalated BSc (Hons) degree in psychology at University College London in 1994. Subsequently, he obtained a Doctor of Medicine higher research degree studying squamous cell carcinoma at King's College London from 2001 to 2003.

Dr Mallipeddi has been professionally recognised as well as by patients. He has been awarded the St John's Dermatological Society registrar prize, the Wooden Curette Award from the British Society for Dermatological Society and named by Marquis (American publisher of directories) as the Who's Who in Healthcare 2009-10. As well as being a highly-qualified professional, Dr Mallipeddi lectures nationally and internationally. He is also heavily involved in medical education as the national curriculum lead for Mohs and Advanced Dermatological Surgery and he has written the "practical procedures" chapter in the "ABC of Dermatology" book. 

He is also widely published, and a pioneer in his field for being one of the only UK doctors who has completed advanced training in Mohs micrographic surgery as certified by the American College of Mohs Surgery. He serves on numerous boards including chair of the UK Mohs micrographic service standards committee and was the past President of the British Society for Dermatological Surgery (2015-2017). Furthermore, he is past president of the St John's Dermatological Society (2021-2022). 

He was a member of the British Association of Dermatologists' (BAD) guideline committees for basal cell carcinoma, squamous cell carcinoma and photodynamic therapy and has helped to develop important national guidelines.

View Profile

Overall assessment of their patients


  • Related procedures
  • Laser
    Microdermoabrasion
    Treatment pigmented lesions
    Microneedling
    Platelet-rich plasma
    Dark circles
    Radiofrequency Facelift
    Lifting by radiofrequency
    Hands rejuvenation
    Cryolipolysis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.